Stephanie Gaillard

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Blueprint
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Compugen
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Curio Science
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GenenTech/Roche
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GOG/Clovis
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Immunogen
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    lovance
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lumanity
    Date added:
    08/29/2023
    Date updated:
    08/29/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    NCTN
    Date added:
    08/29/2023
    Date updated:
    08/29/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond